Cargando…

Feasibility of MR-guided ultrahypofractionated radiotherapy in 5, 2 or 1 fractions for prostate cancer

The drive towards hypofractionated prostate radiotherapy is motivated by a low alpha/beta ratio for prostate cancer (1 to 3 Gy) compared to surrounding organs at risk, implying an improved therapeutic ratio with increasing dose per fraction. Early evidence from studies of ultrahypofractionated (UHF)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohajer, Jonathan, Dunlop, Alex, Mitchell, Adam, Goodwin, Edmund, Nill, Simeon, Oelfke, Uwe, Tree, Alison
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674276/ https://www.ncbi.nlm.nih.gov/pubmed/33241129 http://dx.doi.org/10.1016/j.ctro.2020.10.005

Ejemplares similares

Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linac
por: Dunlop, Alex, et al.
Publicado: (2020)

Automatic reconstruction of the delivered dose of the day using MR-linac treatment log files and online MR imaging
por: Menten, Martin J., et al.
Publicado: (2020)

Dosimetric comparison of automatically propagated prostate contours with manually drawn contours in MRI-guided radiotherapy: A step towards a contouring free workflow?
por: Sritharan, Kobika, et al.
Publicado: (2022)

Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac
por: Mitchell, A., et al.
Publicado: (2022)

MRI-guided adaptive radiotherapy for prostate cancer: When do we need to account for intra-fraction motion?
por: Lawes, R., et al.
Publicado: (2022)

Bladder filling in patients undergoing prostate radiotherapy on a MR-linac: The dosimetric impact
por: Smith, Gillian Adair, et al.
Publicado: (2022)

Comparison of the dose escalation potential for two hypofractionated radiotherapy regimens for locally advanced pancreatic cancer
por: Bertholet, Jenny, et al.
Publicado: (2019)

Treating locally advanced lung cancer with a 1.5 T MR-Linac – Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy
por: Bainbridge, Hannah E., et al.
Publicado: (2017)

Evaluation of non-vendor magnetic resonance imaging sequences for use in bladder cancer magnetic resonance image guided radiotherapy
por: Chick, Joan, et al.
Publicado: (2023)

Online adaptive radiotherapy for head and neck cancers on the MR linear Accelerator: Introducing a novel modified Adapt-to-Shape approach
por: Gupta, Amit, et al.
Publicado: (2021)

The impact of 2D cine MR imaging parameters on automated tumor and organ localization for MR-guided real-time adaptive radiotherapy
por: Menten, Martin J, et al.
Publicado: (2018)

New target volume delineation and PTV strategies to further personalise radiotherapy
por: Bernstein, David, et al.
Publicado: (2021)

Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Lung stereotactic body radiotherapy with an MR-linac – Quantifying the impact of the magnetic field and real-time tumor tracking
por: Menten, Martin J., et al.
Publicado: (2016)

Synthetic 4D-CT of the thorax for treatment plan adaptation on MR-guided radiotherapy systems
por: Freedman, Joshua N, et al.
Publicado: (2019)

Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer
por: Hunt, A., et al.
Publicado: (2020)

Beam selection for stereotactic ablative radiotherapy using Cyberknife with multileaf collimation
por: Bedford, James L., et al.
Publicado: (2019)

Multi-institutional retrospective analysis of ultrahypofractionated radiotherapy for Japanese prostate cancer patients
por: Ishiyama, Hiromichi, et al.
Publicado: (2021)

MR-Guided Radiotherapy for Prostate Cancer
por: Tocco, Boris R., et al.
Publicado: (2020)

MR-guided radiotherapy for prostate cancer: state of the art and future perspectives
por: Sritharan, Kobika, et al.
Publicado: (2022)

Comment on Hunt et al., “Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer”
por: Hafeez, S., et al.
Publicado: (2021)

Evaluation of therapeutic radiographer contouring for magnetic resonance image guided online adaptive prostate radiotherapy
por: Adair Smith, Gillian, et al.
Publicado: (2023)

MRI-Guided Radiation Therapy for Prostate Cancer: The Next Frontier in Ultrahypofractionation
por: Benitez, Cecil M., et al.
Publicado: (2023)

IMRT‐application with an add‐on MMLC
por: Tücking, Thomas, et al.
Publicado: (2003)

Comparison of toxicities between ultrahypofractionated radiotherapy versus brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2022)

Motion monitoring during a course of lung radiotherapy with anchored electromagnetic transponders: Quantification of inter- and intrafraction motion and variability of relative transponder positions
por: Schmitt, Daniela, et al.
Publicado: (2017)

Evaluation of inter- and intrafractional motion of liver tumors using interstitial markers and implantable electromagnetic radiotransmitters in the context of image-guided radiotherapy (IGRT) – the ESMERALDA trial
por: Habermehl, Daniel, et al.
Publicado: (2015)

Dosimetric accuracy of delivering SBRT using dynamic arcs on Cyberknife
por: Bedford, James L., et al.
Publicado: (2020)

Dosimetric evaluation of photons versus protons in postmastectomy planning for ultrahypofractionated breast radiotherapy
por: Oonsiri, Puntiwa, et al.
Publicado: (2022)

Iterative framework for the joint segmentation and CT synthesis of MR images: application to MRI-only radiotherapy treatment planning
por: Burgos, Ninon, et al.
Publicado: (2017)

Prostate Ultrahypofractionation – Rising to Challenges Presents Opportunities in the COVID-19 Era
por: Griffiths, W., et al.
Publicado: (2021)

Realizing the potential of magnetic resonance image guided radiotherapy in gynaecological and rectal cancer
por: White, Ingrid M, et al.
Publicado: (2019)

Ultrahypofractionation of localized prostate cancer: Statement from the DEGRO working group prostate cancer
por: Wolf, Frank, et al.
Publicado: (2020)

Prostate cancer – Advantages and disadvantages of MR-guided RT
por: Murray, Julia, et al.
Publicado: (2019)

Comparison of prostate delineation on multimodality imaging for MR-guided radiotherapy
por: Pathmanathan, Angela U, et al.
Publicado: (2019)

Super-resolution T2-weighted 4D MRI for image guided radiotherapy
por: Freedman, Joshua N., et al.
Publicado: (2018)

Case report: Ultrahypofractionated palliative breast radiotherapy for a fungating invasive mammary carcinoma
por: Hong, Yejun, et al.
Publicado: (2023)

Treatment planning optimization with beam motion modeling for dynamic arc delivery of SBRT using Cyberknife with multileaf collimation
por: Bedford, James L., et al.
Publicado: (2019)

A phase space model of a Versa HD linear accelerator for application to Monte Carlo dose calculation in a real‐time adaptive workflow
por: Bedford, James L., et al.
Publicado: (2022)

Laser-free pelvic alignment in an online adaptive radiotherapy environment
por: Barnes, Helen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_irt30q14a0l1ehb4nkbe6se08s